DexCom ROE 2010-2024 | DXCM

Current and historical return on equity (ROE) values for DexCom (DXCM) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
DexCom ROE - Return on Equity Historical Data
Date TTM Net Income Shareholder's Equity Return on Equity
2024-12-31 $0.58B $2.10B 26.34%
2024-09-30 $0.68B $1.98B 31.21%
2024-06-30 $0.67B $2.43B 29.59%
2024-03-31 $0.64B $2.25B 29.43%
2023-12-31 $0.54B $2.07B 25.01%
2023-09-30 $0.38B $2.27B 17.31%
2023-06-30 $0.36B $2.10B 17.27%
2023-03-31 $0.29B $2.23B 13.88%
2022-12-31 $0.34B $2.13B 16.23%
2022-09-30 $0.24B $1.83B 11.74%
2022-06-30 $0.23B $2.26B 10.67%
2022-03-31 $0.26B $2.19B 12.29%
2021-12-31 $0.22B $2.04B 10.74%
2021-09-30 $0.63B $2.14B 32.20%
2021-06-30 $0.62B $2.00B 34.21%
2021-03-31 $0.59B $1.90B 35.61%
2020-12-31 $0.55B $1.83B 39.11%
2020-09-30 $0.23B $1.50B 19.78%
2020-06-30 $0.21B $1.35B 20.83%
2020-03-31 $0.15B $0.94B 18.10%
2019-12-31 $0.10B $0.88B 13.45%
2019-09-30 $-0.17B $0.76B -24.71%
2019-06-30 $-0.17B $0.69B -26.49%
2019-03-31 $-0.13B $0.67B -21.89%
2018-12-31 $-0.13B $0.66B -23.86%
2018-09-30 $0.04B $0.56B 9.34%
2018-06-30 $-0.01B $0.48B -1.17%
2018-03-31 $-0.03B $0.42B -8.11%
2017-12-31 $-0.05B $0.42B -13.94%
2017-09-30 $-0.05B $0.38B -14.77%
2017-06-30 $-0.07B $0.35B -22.07%
2017-03-31 $-0.09B $0.28B -32.90%
2016-12-31 $-0.07B $0.28B -25.42%
2016-09-30 $-0.06B $0.26B -23.33%
2016-06-30 $-0.08B $0.25B -35.91%
2016-03-31 $-0.06B $0.23B -31.37%
2015-12-31 $-0.06B $0.22B -31.61%
2015-09-30 $-0.06B $0.19B -36.14%
2015-06-30 $-0.02B $0.17B -14.61%
2015-03-31 $-0.02B $0.15B -18.25%
2014-12-31 $-0.02B $0.14B -20.67%
2014-09-30 $-0.03B $0.12B -27.76%
2014-06-30 $-0.03B $0.10B -32.09%
2014-03-31 $-0.03B $0.09B -39.88%
2013-12-31 $-0.03B $0.08B -39.34%
2013-09-30 $-0.04B $0.08B -46.98%
2013-06-30 $-0.05B $0.07B -60.73%
2013-03-31 $-0.05B $0.07B -63.35%
2012-12-31 $-0.05B $0.08B -62.07%
2012-09-30 $-0.06B $0.08B -61.70%
2012-06-30 $-0.05B $0.09B -52.81%
2012-03-31 $-0.05B $0.10B -41.82%
2011-12-31 $-0.04B $0.11B -44.78%
2011-09-30 $-0.04B $0.11B -48.14%
2011-06-30 $-0.04B $0.12B -61.99%
2011-03-31 $-0.05B $0.05B -98.95%
2010-12-31 $-0.06B $0.06B -119.57%
2010-09-30 $-0.06B $0.04B -217.14%
2010-06-30 $-0.06B $0.04B -380.33%
2010-03-31 $-0.06B $0.05B -1109.09%
2009-12-31 $-0.05B $-0.02B 2160.00%
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $27.989B $4.033B
DexCom, Inc. is a medical device company focused on the design, development and commercialization of continuous glucose monitoring systems (CGM). These are for ambulatory use by people with diabetes and by healthcare providers for the treatment of diabetic and non-diabetic patients. A key element of DexCom's monitoring system technology is the continuous measure of patient's blood glucose level and transmission of that information to a small cell phone-sized receiver in real time. The company's monitoring systems aim to provide real-time continuous blood glucose values, trend data and alerts to assist patients in managing their blood glucose levels.
Stock Name Country Market Cap PE Ratio
Intuitive Surgical (ISRG) United States $184.872B 80.97
Thermo Fisher Scientific (TMO) United States $161.944B 19.59
Alcon (ALC) Switzerland $48.146B 32.00
Edwards Lifesciences (EW) United States $44.378B 29.03
IDEXX Laboratories (IDXX) United States $35.062B 40.55
IQVIA Holdings (IQV) United States $27.341B 15.13
Mettler-Toledo (MTD) United States $22.312B 26.01
STERIS (STE) Ireland $22.081B 25.25
Waters (WAT) United States $20.688B 29.30
SONOVA HOLDING (SONVY) Switzerland $18.273B 0.00
Hologic (HOLX) United States $13.059B 14.09
Sysmex ADR (SSMXY) Japan $11.620B 0.00
Penumbra (PEN) United States $11.341B 89.01
Globus Medical (GMED) United States $9.871B 22.86
Masimo (MASI) United States $8.698B 36.50
Teleflex (TFX) United States $6.355B 9.78
Glaukos (GKOS) United States $5.380B 0.00
Integer Holdings (ITGR) United States $4.407B 23.09
TransMedics (TMDX) United States $3.112B 91.10
PROCEPT BioRobotics (PRCT) United States $2.986B 0.00
Veracyte (VCYT) United States $2.389B 42.96
LivaNova (LIVN) United Kingdom $2.011B 12.21
Nihon Kohden (NHNKY) Japan $1.969B 10.77
Elekta AB (EKTAY) Sweden $1.945B 17.48
Alphatec Holdings (ATEC) United States $1.604B 0.00
Integra LifeSciences Holdings (IART) United States $1.266B 6.40
Pulse Biosciences (PLSE) United States $1.145B 0.00
Tandem Diabetes Care (TNDM) United States $1.122B 0.00
Artivion (AORT) United States $1.011B 94.76
OPKO Health (OPK) United States $0.927B 0.00
AxoGen (AXGN) United States $0.721B 0.00
IRadimed (IRMD) United States $0.666B 34.94
Mesa Laboratories (MLAB) United States $0.626B 13.69
RxSight (RXST) United States $0.598B 0.00
SiBone (SIBN) United States $0.581B 0.00
AVANOS MEDICAL, INC (AVNS) United States $0.577B 9.30
ORTHOFIX MEDICAL INC (OFIX) United States $0.543B 0.00
OrthoPediatrics (KIDS) United States $0.506B 0.00
Beta Bionics (BBNX) United States $0.479B 0.00
Treace Medical Concepts (TMCI) United States $0.445B 0.00
ClearPoint Neuro (CLPT) United States $0.403B 0.00
Delcath Systems (DCTH) United States $0.403B 0.00
NeuroPace (NPCE) United States $0.383B 0.00
AngioDynamics (ANGO) United States $0.377B 0.00
Tactile Systems Technology (TCMD) United States $0.334B 17.87
Pacific Biosciences Of California (PACB) United States $0.333B 0.00
Semler Scientific (SMLR) United States $0.310B 6.58
Neuronetics (STIM) United States $0.288B 0.00
908 Devices (MASS) United States $0.194B 0.00
Inogen (INGN) United States $0.192B 0.00
CVRx (CVRX) United States $0.191B 0.00
Alpha Tau Medical (DRTS) Israel $0.180B 0.00
Anteris Technologies Global (AVR) Australia $0.179B 0.00
LENSAR (LNSR) United States $0.166B 0.00
Spectral Diagnostics (EDTXF) Canada $0.165B 0.00
Accuray (ARAY) United States $0.159B 0.00
Sight Sciences (SGHT) United States $0.158B 0.00
Lucid Diagnostics (LUCD) United States $0.132B 0.00
KORU Medical Systems (KRMD) United States $0.127B 0.00
Atossa Genetics (ATOS) United States $0.116B 0.00
Monogram Orthopaedics (MGRM) United States $0.108B 0.00
Rapid Micro Biosystems (RPID) United States $0.100B 0.00
Microbot Medical (MBOT) United States $0.086B 0.00
EDAP TMS S.A (EDAP) France $0.079B 0.00
InspireMD (NSPR) Israel $0.078B 0.00
Sensus Healthcare (SRTS) United States $0.071B 10.75
Hyperfine (HYPR) United States $0.056B 0.00
Zomedica (ZOMDF) United States $0.055B 0.00
EnVVeno Medical (NVNO) United States $0.053B 0.00
Vicarious Surgical (RBOT) United States $0.049B 0.00
Baird Medical Investment Holdings (BDMD) $0.038B 0.00
Precision Optics (POCI) United States $0.034B 0.00
Spectral AI (MDAI) United States $0.033B 0.00
Envoy Medical (COCH) United States $0.030B 0.00
DarioHealth (DRIO) United States $0.030B 0.00
Biosig Technologies (BSGM) United States $0.025B 0.00
NexGel (NXGL) United States $0.020B 0.00
Adagio Medical Holdings (ADGM) United States $0.020B 0.00
Ekso Bionics Holdings (EKSO) United States $0.014B 0.00
Accelerate Diagnostics (AXDX) United States $0.013B 0.00
PAVmed (PAVM) United States $0.012B 0.00
Inspira Technologies OXY B.H.N (IINN) Israel $0.007B 0.00
SINTX TECHNOLOGIES, INC (SINT) United States $0.007B 0.00
Tenon Medical (TNON) United States $0.007B 0.00
WORK Medical Technology Group (WOK) China $0.006B 0.00
Autonomix Medical (AMIX) United States $0.006B 0.00
Check-Cap (CHEK) Israel $0.005B 0.00
Nuwellis (NUWE) United States $0.004B 0.00
ReShape Lifesciences (RSLS) United States $0.004B 0.00
Venus Concept (VERO) Canada $0.003B 0.00
ENDRA Life Sciences (NDRA) United States $0.003B 0.00
Nanovibronix (NAOV) United States $0.002B 0.00
Avinger (AVGR) United States $0.002B 0.00
Helius Medical Technologies (HSDT) United States $0.001B 0.00
Bluejay Diagnostics (BJDX) United States $0.001B 0.00
Spinal Elements Holdings (SPEL) United States $0.000B 0.00
Longview Acquisition II (LGV) United States $0.000B 0.00
Fresenius Medical Care AG KGaA (FMS) Germany $0.000B 15.20